United States · Wires & real time · PR Newswire
Ractigen Therapeutics Publishes Foundational Study on its Extrahepatic LiCO™ Delivery Platform in Molecular Therapy - Nucleic Acids
Peer-reviewed study demonstrates potent, multi-month extrahepatic delivery via both systemic administration—targeting skeletal muscle, heart, and adipose tissue—and localized…
Read the full article on PR Newswire Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.prnewswire.com)
